Literature DB >> 32968822

Outcomes of Right Ventricular Outflow Tract Reconstruction in Children: Retrospective Comparison Between Bovine Jugular Vein and Expanded Polytetrafluoroethylene Conduits.

Kenta Hirai1, Kenji Baba2, Takuya Goto3, Daiki Ousaka3, Maiko Kondo1, Takahiro Eitoku1, Yasuhiro Kotani3, Shingo Kasahara3, Shinichi Ohtsuki1, Hirokazu Tsukahara1.   

Abstract

Bovine jugular vein (BJV) and expanded polytetrafluoroethylene (ePTFE) conduits have been described as alternatives to the homograft for right ventricular outflow tract (RVOT) reconstruction. This study compared RVOT reconstructions using BJV and ePTFE conduits performed in a single institution. The valve functions and outcomes of patients aged < 18 years who underwent primary RVOT reconstruction with a BJV or ePTFE conduit between 2013 and 2017 were retrospectively investigated. 44 patients (20 and 24 with BJV and ePTFE conduits, respectively) met the inclusion criteria. The mean follow-up time was 4.5 ± 1.5 years. No significant differences in peak RVOT velocity (1.8 ± 0.9 m/s vs 2.1 ± 0.9 m/s, P = 0.27), branch pulmonary stenosis (P = 0.50), or pulmonary regurgitation (P = 0.44) were found between the BJV and ePTFE conduit groups, respectively. Aneurysmal dilatation of the conduit was observed in 25.0% of the patients in the BJV conduit group but not in the ePTFE conduit group (P = 0.011). All the cases with aneurysmal dilatation of the BJV conduit were complicated with branch pulmonary stenosis up to 3.0 m/s (P = 0.004). No conduit infections occurred during the follow-up period, and no significant difference in conduit replacement (20.0% vs 8.3%, P = 0.43) was found between the BJV and ePTFE conduit groups, respectively. The outcomes of the RVOT reconstructions with BJV and ePTFE conduits were clinically satisfactory. Aneurysmal dilatation was found in the BJV conduit cases, with branch pulmonary stenosis as the risk factor.

Entities:  

Keywords:  Conduit; Pulmonary stenosis; Rastelli operation; Right ventricular outflow tract

Year:  2020        PMID: 32968822     DOI: 10.1007/s00246-020-02458-0

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  2 in total

1.  The contegra® valved heterograft conduit for right ventricular outflow tract reconstruction: a reliable solution.

Authors:  Panagiotis G Sfyridis; Dimosthenis P Avramidis; George V Kirvassilis; Prodromos N Zavaropoulos; John K Papagiannis; George E Sarris
Journal:  Hellenic J Cardiol       Date:  2011 Nov-Dec

2.  The Contegra conduit in the right ventricular outflow tract is an independent risk factor for graft replacement.

Authors:  Stefano Urso; Filip Rega; Bart Meuris; Marc Gewillig; Benedicte Eyskens; Willem Daenen; Ruth Heying; Bart Meyns
Journal:  Eur J Cardiothorac Surg       Date:  2011-02-19       Impact factor: 4.191

  2 in total
  2 in total

1.  Mid-term outcomes of Contegra implantation for the reconstruction of the right ventricular outflow tract to proximal branch pulmonary arteries: Japan multicentre study.

Authors:  Takaya Hoashi; Hajime Ichikawa; Keiichi Hirose; Naohiro Horio; Takahisa Sakurai; Hironori Matsuhisa; Yoshihiro Ohsima; Hajime Sakurai; Shingo Kasahara; Kisaburo Sakamoto
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-07-26

Review 2.  Current development of bovine jugular vein conduit for right ventricular outflow tract reconstruction.

Authors:  Chenggang Li; Bo Xie; Ruizhe Tan; Lijin Liang; Zhaoxiang Peng; Qi Chen
Journal:  Front Bioeng Biotechnol       Date:  2022-08-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.